EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...

and lead author of a New England Journal of Medicine paper outlining the findings said: “There is good scientific rationale for combining Keytruda with pemetrexed and platinum chemotherapy ...

The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 ...

The filing – which triggers a milestone payment from AZ – is supported by the SACHI trial, which compared Orpathys and Tagrisso to platinum-based doublet-chemotherapy (pemetrexed plus ...

We detected a correlation between the response to pemetrexed/cisplatin and the observed clinical ... the Target Discovery Institute and the Nuffield Department of Medicine, University of Oxford for ...

According to GlobalData, Phase II drugs for Small-Cell Lung Cancer have a 26% phase ... Idafang is indicated along with pemetrexed and carboplatin for the treatment of patients with locally advanced ...

BGC-0228 is under clinical development by BrightGene Bio-Medical Technology and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData, Phase I drugs for Metastatic Pancreatic ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Doctors and their patients discuss the range of services that Duke Cancer Institute provides to teens and younger adults with a history of cancer. Beyond Cancer: Mental Health and Therapy Duke ...

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...